- Filed
- Apr 23, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 21, 2026 | 292.82M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 296.99M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 302.91M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $530M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $418M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$825M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$546M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $5.02B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.05B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $2.86B |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $2.47B |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.66B |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $1.86B |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $8.52B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $8.88B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.75B |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.32B |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $20.86B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $21.25B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $12.73B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $13.49B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $30.17B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $30.88B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $1.07 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.54 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $1.08 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.54 |
| Net Income | Q1 2026 · Mar 31, 2026 | $318M |
| Net Income | Q1 2026 · Mar 31, 2025 | $163M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $511M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $276M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $8.68B |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $7.27B |
| Revenue | Q1 2026 · Mar 31, 2026 | $10.42B |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $8.78B |